Benzinga's Top #PreMarket Losers

Intercept Pharmaceuticals ICPT shares fell 21.49% to $350.00 in the pre-market trading after the company announced an additional detail about FLINT Trial provided by NIDDIK. SodaStream International SODA dipped 17% to $41.40 in the pre-market session after the company lowered its FY13 forecast. Lululemon Athletica LULU dipped 12.69% to $52.00 after the company cut its outlook. Prosensa Holding NV RNA shares dropped 7.66% to $5.18 in pre-market trading after the company reported that it has regained all rights from GlaxoSmithKline GSK to drisapersen and will retain rights to all other programs for the treatment of Duchenne Muscular Dystrop.